Indication
Diffuse Large B-Cell
2 clinical trials
2 products
Product
PNT2258Clinical trial
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell LymphomaStatus: Completed, Estimated PCD: 2016-07-11
Clinical trial
Prospective Observational Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-CellStatus: Active (not recruiting), Estimated PCD: 2020-12-30
Product
R-CHOP